All Type of News
Korea to select 50 innovative pharmaceutical firms
The government unveiled its plan to select 50 companies as “innovative pharmaceutical firms,” subject to tax deduction, price raises, financial aid, research and development support and other benefits, while scrutiniz...
'Dumping' war looming in national hospital bidding market
The national and public hospital market competition is expected to heat up this year, as fiercer competition has prompted pharmaceutical wholesalers to rekindle their reckless bidding practice to recover lost sales, a...
Pharmaceutical firms urged to take higher social responsibility profile
Corporate Social Responsibility (CSR), an issue of policy debates on corporate agendas, has recently emerged as an essential condition for sustainable growth of enterprises in the changing business environment of the ...
Green Cross posts largest per-capita sale
Green Cross Corp. was the nation's most economically active drug firm in 2011, with its per-capita revenue topping the list among 53 pharmaceutical companies listed on the Korea Exchange market.
Yakup.com, a pharma...
Korean medicines are not expensive
The Korean Pharmaceutical Manufacturers Association (KPMA) expressed a deep regret over the recent online survey of local doctors that Korea’s generics are expensive by global standards, which was released by the Heal...
CJ forges strategic tie-up with Japanese firm
CJ Jeil Chedang said Friday that it has forged a strategic alliance with Asai Kasei Medical Co., a leading Japanese medical device firm, in an effort to distribute Asahi’s hemodialysis products in Korea.
Under the ...
Hanmi’s Hyaluma inj. wins SCG certification
Hanmi Pharmaceutical said Monday that it has acquired the British SGS (Society of General Surveillance) certification for Hyaluma injection (sodium hyaluronate as a medical device.
Sodium hyaluronate is used as a v...
Ildong brings in Ohta’s Isan brands
Ildong Pharmaceutical said Friday that it has established a marketing and distribution partnership with Ohta’s Isan Co. in Japan.
Under the deal, Ildong will bring Ohta’s Isan Antacid tablets, one of the most trust...
Ilsung, Dalim withdraw suit
Four drug companies filed a suit against the Ministry of Health and Welfare on March 7 and March 9, claiming the government’s drug price cuts will deal a big blow to their revenues.
However, Ilsung Pharmaceutical a...
KPMA to reinforce advisory body’s function
The Korea Pharmaceutical Manufacturers Association unveiled its plan to strengthen the function of its advisory committee consisting of 13 high-profile figures from leading drug firms.
In a board of directors’ meet...
